Training Acamprosate Anti-Craving Medication for Alcoholism

SAMHSA Launches E-Learning Courses

The US Substance Abuse and Mental Health Services Administration’s (SAMHSA’s) Knowledge Application Program (KAP) is pleased to announce its first online e-learning course,

Acamprosate: A New Medication for Alcohol Use Disorders.

The self-paced course provides information about the use, side effects, and contraindications of acamprosate; information to discuss with clients; and a comparison of medications for alcohol use disorders. On completion of the course, users will know how to include acamprosate in a treatment plan for appropriate clients.

The course is based on the acamprosate Substance Abuse Treatment Advisory published in fall 2005. Users who successfully complete the course will receive one NAADAC-approved continuing education unit (CEU) at no cost and can print out their CEU certificate.

The course is self-paced so that users can log out of the course and return at a later time to continue where they left off. If unsuccessful, users can take the course again.

To access the “Acamprosate: A New Medication for Alcohol Use Disorders” e-learning course, go to www.kap-elearning.samhsa.gov.

See also; Brief-TSF can assist patients cease alcohol consumption.